Life Science Company News

Reset
Results 161 - 180 out of 500 displayed.
«  1  2  3  4  5  6  7  8 9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  FibroBiologics Inc.

Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Aligos Therapeutics, Inc.

AssistRx Launches Advanced Access Anywhere to Expedite Access and Automate Enrollment at the Point of Pharmacy Claim

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  AssistRx, LLC

Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ET

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Aquestive Therapeutics, Inc.

Tilray Brands Celebrates Epic 420 Weekend With Over 20,000 Fans Across the U.S.

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Tilray Inc.

Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Candel Therapeutics, Inc.

BioStem Technologies to Present at the 2024 Planet MicroCap Showcase

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  BioStem Technologies, Inc.

Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Sensus Healthcare, Inc.

Compass Therapeutics Receives FDA Fast Track Designation for the Investigation of CTX-009 in Combination with Paclitaxel for the Treatment of Patients with Metastatic or Locally Advanced Biliary Tract Tumors That Have Been Previously Treated

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Compass Therapeutics, Inc.

MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  MediWound Ltd.

iSpecimen to Report First Quarter 2024 Financial Results on May 7, 2024

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  iSpecimen

Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Achieve Life Sciences, Inc.

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Collegium Pharmaceutical, Inc.

Promising perspectives for the application of SDS Optic’s inPROBE technology platform for protein expression determination

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  SDS OPTIC Sp. z o.o.

Cerevance Adds $47 Million in Series B-1 Extension to Advance Robust Clinical Pipeline

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Cerevance Inc. | Cerevance Inc.

American Oncology Cares Foundation Expands Non-Medical Financial Support to Local Cancer Patients in Indiana and Nevada

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  American Oncology Network, LLC

Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Assertio Holdings, Inc.

Theriva™ Biologics to Discuss the Trial Design for VIRAGE - a Phase 2b Clinical Study of Systemically Administered VCN-01 in Combination with Chemotherapy in Pancreatic Ductal Adenocarcinoma - at the 2024 American Society of Clinical Oncology (ASCO)

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Theriva Biologics, Inc.

Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Autonomix Medical, Inc.

Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Apollomics, Inc.
Results 161 - 180 out of 500 displayed.
«  1  2  3  4  5  6  7  8 9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »